LA JOLLA PHARMACE

LA JOLLA PHARMACEUTICAL COMPANY (LJPC)
www.ljpc.com
Prezzo Variazione Volume P/E
22.85 +0.44 €
(+1.96%)
0 -3.19

Grafico

Altri utenti che hanno investito

Transations in last week
Buy: 24
Sell : 20

DaniB21B Andrea Scu Antonio Marenna Emanuele Nessuno Winston Tiaril Finalx Giuseppe Mariani

Commenti

Notizie

This RSS feed URL is deprecated

Leggi

Why La Jolla Pharmaceutical Is Tumbling Today - Motley Fool

Shares of La Jolla Pharmaceutical Company (NASDAQ:LJPC), a commercial-stage biopharma focused on life-threating diseases, were down 21% as of 11:55 a.m. EDT Thursday. ... The lower-than-hoped-for results caused traders to head for the exits. Leggi

Here's What To Do With Idera Pharmaceuticals, Inc. (IDRA), La Jolla Pharmaceutical Company (LJPC) - Post Analyst

Optimism reigned on a dull-volume day for Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) which added $1.18 between open and close. The number of shares traders wanted to buy or sell IDRA was around 2.1 million shares compared with the full-day average ... Leggi

The Daily Biotech Pulse: No Anxiety For Biohaven, Strongbridge's About-Face, Bristol-Myers Squibb's FDA Wait - Benzinga

Biohaven Pharmaceutical Holding Co Ltd (NYSE: BHVN) said its BHV-0223, an experimental candidate to treat patients with social anxiety disorder and public speaking anxiety, met the primary endpoint in a proof-of-concept trial. "Trial results support ... Leggi

Factors of Influence in 2018, Key Indicators and Opportunity within Celsion, Alpha and Omega Semiconductor, SP Plus ... - GlobeNewswire (press release)

Factors of Influence in 2018, Key Indicators and Opportunity within Celsion, Alpha and Omega Semiconductor, SP Plus, Merrimack Pharmaceuticals, La Jolla Pharmaceutical, and SPX — New Research Emphasizes Economic Growth ... traders, and shareholders of ... Leggi

Analyst-Turned-CEO Says His Biotech Stock Is Cheap, Even After a 900% Rally - Bloomberg

So far most of Viking's value -- shares soared over 900 percent the past year -- has been driven by a competitor's results in treating nonalcoholic steatohepatitis, or NASH. When Madrigal Pharmaceuticals Inc. climbed on NASH data and takeover ... Leggi

Which Market Offer More Value? – Adamas Pharmaceuticals, Inc. (ADMS), La Jolla Pharmaceutical Company (LJPC) - StockNewsGazette

The shares of Adamas Pharmaceuticals, Inc. have decreased by more than -23.72% this year alone. The shares recently went up by 3.86% or $0.96 and now trades at $25.85. The shares of La Jolla Pharmaceutical Company (NASDAQ:LJPC), has jumped by ... Leggi

HC Wainwright Reaffirms “Buy” Rating for La Jolla Pharmaceutical ... - XNewsPress

HC Wainwright reiterated their buy rating on shares of La Jolla Pharmaceutical (NASDAQ:LJPC) in a report published on Thursday, August 9th. The brokerage ...altro » Leggi

20 Composite Equities and Shares Suffer Late Losses, Aug. 10 - FxPips.com

e.l.f. Beauty (ELF) has posted a closing price of $9.85 down 33.94 percent on 9,073,632 total traded shares. Electrameccanica Vehicles (SOLO) has posted a closing price of $2.40 down 26.15 percent on 651,239 total traded shares. La Jolla Pharmaceutical ... Leggi

Emory University Has Trimmed Its Position in Seagate Technology Plc (STX) by $344404; Chilton Capital Management ... - The Cardinal Weekly (press release)

The stock increased 2.00% or $4.26 during the last trading session, reaching $217.58. About 34.82 million shares traded or 46.29% up from the average. Apple Inc. (NASDAQ:AAPL) has risen ... according to the filing. It also increased its holding in La ...altro » Leggi

Cna Financial Boosted Eaton Plc (ETN) Stake; Emory University Upped La Jolla Pharmaceutical Co (LJPC) Position By ... - Z Tribune

The stock increased 3.81% or $1.25 during the last trading session, reaching $34.02. About 904,487 shares traded or 170.44% up from the average. La Jolla Pharmaceutical Company (NASDAQ:LJPC) has risen 9.85% since August 5, 2017 and is uptrending.altro » Leggi